Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Horm Metab Res ; 46(13): 911-20, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25473824

ABSTRACT

Recent studies in USA, Europe, and across the world have revealed a continuous increase of mean birth weight in the last 2 decades. Strong evidence exists from several studies indicating that individuals born with a low birth weight are more likely to present cardiometabolic complications in later life. So far, the long-term consequences of high birth weight have not been clearly defined. This review examines the role of high birth weight on the development of cardiometabolic consequences (obesity, body composition, type 2 diabetes mellitus, and cardiovascular disease) in childhood and adulthood. The majority of the studies show that high BW is associated with an increased risk for obesity. To a certain extent high birth weight affects diseases of the heart and circulatory, but does not constitutes a risk for the development of type 2 diabetes mellitus in the general population. Maternal glycemia and the subsequent fetus hyperinsulinemia appear to be the key component for increased fetal growth. With the increase in incidence of diabetes mellitus and obesity over the years, the number of high birth weight infants is likely to increase. The elucidation of the relationship between high birth weight and the cardiometabolic disorders will be particularly important.


Subject(s)
Birth Weight , Cardiovascular Diseases/metabolism , Diabetes Mellitus, Type 2/metabolism , Aged , Blood Pressure , Body Composition , Cardiovascular Diseases/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Female , Humans , Male , Middle Aged , Time Factors
2.
Lab Anim ; 46(1): 40-5, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22008848

ABSTRACT

Precise calculation of total body surface area (TBSA) or premarked surface areas (P-MSAs) is of great importance in many biomedical applications. The aim of the paper was to present a simple procedure of measurement of P-MSAs in small animals and to determine a more accurate Meeh's constant (k), for a commonly used weight range of laboratory rats. A series of 30 Wistar rats, weighing 195-240 g, were anaesthetized and weighted. The TBSA of each animal was measured using a clear pocket and a planimeter. The data obtained were entered into the Meeh's formula (TBSA = kW(2/3)), the most commonly used for small experimental animals, so that a k value for each animal as well as a mean k value (9.83) were obtained. The TBSA of the animals was also calculated using the aforementioned mean k value and compared with that obtained using k values reported in previous studies. According to our findings, the new mean k value, determined with the use of our procedure of surface area measurement, ensured greater accuracy in the determination of the TBSA of experimental rats of a specific weight range. We also suggest a new procedure of surface area measurement which is easy, accurate and does not require animal sacrifice.


Subject(s)
Body Surface Area , Body Weights and Measures/methods , Rats , Animals , Biometry , Body Weight , Body Weights and Measures/instrumentation , Female , Rats, Wistar
3.
Reprod Biomed Online ; 22(6): 569-82, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21507720

ABSTRACT

Microarray technology is a promising method for investigating gynaecological benign pathology. This systematic review examined various parameters of the design of these studies, the methods used and the gene outcome in these diseases. Electronic searches were performed in Medline (up to April 2009). An overall representation of important genes for each disease detected was performed. The results showed genes were up-regulated or down-regulated. However, studies suffer from several flaws in their design, the sample size employed and the reporting method. In conclusion, a significant amount of work has been performed on benign gynaecological diseases using microarray technology. New trial designs need to be employed that incorporate microarray reporting standards. New research directions should evolve based on these results.


Subject(s)
Female Urogenital Diseases/genetics , Gene Expression Profiling , Microarray Analysis , Animals , Female , Humans , Technology Assessment, Biomedical
4.
Phytomedicine ; 18(7): 579-85, 2011 May 15.
Article in English | MEDLINE | ID: mdl-21111587

ABSTRACT

Oxidative stress is considered as a prominent feature of many acute and chronic diseases as well as of the normal aging process. We examined the effects of intra-peritoneal administration of catechins and EGCG as in vivo inhibitors of oxidative stress induced by ozone administration in two groups of Wistar rats. The first group was treated by intra-peritoneal administration of catechins and EGCG after the administration of ozone and the second group was pretreated by intra-peritoneal administration of catechins and EGCG prior to ozone administration. We determined in blood the activity of the enzymes superoxide dismutase and glutathione peroxidase, total antioxidant capacity, levels of copper and zinc and in urine malonaldehyde contents. Ozone administration resulted in significant reduction of glutathione peroxidase activity, plasma zinc levels and plasma and Red Blood Cells antioxidant capacity. Catechins and EGCG upregulate superoxide dismutase activity and maintain plasma and Red Blood Cells antioxidant capacity. Malonaldehyde levels at the end of the study were significantly increased only in the first group. Our data demonstrate that treatment with catechins and EGCG cannot reverse or prevent the effects of oxidative stress although some modulation occurs.


Subject(s)
Antioxidants/pharmacology , Catechin/analogs & derivatives , Catechin/pharmacology , Oxidative Stress/drug effects , Animals , Antioxidants/administration & dosage , Catechin/administration & dosage , Copper/blood , Copper/urine , Female , Glutathione Peroxidase/blood , Glutathione Peroxidase/drug effects , Injections, Intraperitoneal , Lipid Peroxidation/drug effects , Ozone/adverse effects , Ozone/pharmacokinetics , Rats , Rats, Wistar , Superoxide Dismutase/blood , Superoxide Dismutase/drug effects , Zinc/blood , Zinc/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...